share_log

Appili Therapeutics Inc. Forecasted to Post Q1 2023 Earnings of ($0.03) Per Share (TSE:APL)

Defense World ·  Jul 16, 2022 14:51

Appili Therapeutics Inc. (TSE:APL – Get Rating) – Equities researchers at Zacks Small Cap issued their Q1 2023 earnings per share (EPS) estimates for shares of Appili Therapeutics in a research note issued on Thursday, July 14th. Zacks Small Cap analyst D. Bautz anticipates that the company will post earnings per share of ($0.03) for the quarter. Zacks Small Cap also issued estimates for Appili Therapeutics' Q2 2023 earnings at ($0.02) EPS, Q3 2023 earnings at ($0.02) EPS and Q4 2023 earnings at ($0.02) EPS.

Appili Therapeutics Price Performance

See Also

  • MarketBeat: Week in Review 7/11 – 7/15
  • Is Coupang's Stock On The Verge Of A Turnaround?
  • Should You Have These Two Banks In Your Portfolio?
  • Verint Systems Stock is a Customer Engagement Play
  • Why Shopify Stock Split...And is as Shoppable as Ever

Receive News & Ratings for Appili Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Appili Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment